Aurobindo Pharma reported INR75.31B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Cipla INR 59.27B 1.71B Mar/2026
Divis Laboratories Ltd INR 20.17B 1.85B Mar/2026
Dr.Reddys Laboratories INR 74.58B 977M Mar/2026
Hindustan Unilever INR 128.58B 1.32B Mar/2026
Sun Pharmaceuticals INR 114.07B 2.96B Dec/2025
UPL INR 156.03B 49.4B Mar/2026